Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia

Publication date: Available online 23 May 2021Source: Journal of Pharmacological SciencesAuthor(s): Megumi Kikuya, Kenta Furuichi, Takuya Hirao, Satoshi Endo, Naoki Toyooka, Kousei Ito, Shigeki Aoki
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research